1. Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity

   • Maria J. Pereira
   • Jan W. Eriksson

   Leading Article Open access 30 January 2019 Pages: 219 - 230

   

2. The Impact of Comorbidities on the Pharmacological Management of Type 2 Diabetes Mellitus

   • Shazia Hussain
   • Tahseen A. Chowdhury

   Therapy in Practice 11 February 2019 Pages: 231 - 242

   

3. Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections

   • Khalid Eljaaly
   • Aisha Alharbi
   • Jason M. Pogue

   Review Article 06 February 2019 Pages: 243 - 269

   

4. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli

   • George G. Zhanel
   • Alyssa R. Golden
   • James A. Karlowsky

   Review Article 02 February 2019 Pages: 271 - 289

   

5. Betrixaban for Extended Venous Thromboembolism Prophylaxis in High-Risk Hospitalized Patients: Putting the APEX Results into Practice

   • Kayla M. Miller
   • Michael J. Brenner

   Review Article 05 February 2019 Pages: 291 - 302

6. Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease

   • Hannah A. Blair

   Adis Drug Evaluation 28 January 2019 Pages: 303 - 313

7. Eravacycline: A Review in Complicated Intra-Abdominal Infections

   • Lesley J. Scott

   Adis Drug Evaluation Open access 20 February 2019 Pages: 315 - 324

8. Sarecycline: First Global Approval

   • Emma D. Deeks

   AdisInsight Report Open access 18 January 2019 Pages: 325 - 329

   

9. Gilteritinib: First Global Approval

   • Sohita Dhillon

   AdisInsight Report 05 February 2019 Pages: 331 - 339

   

10. Sintilimab: First Global Approval

    • Sheridan M. Hoy

    AdisInsight Report 11 February 2019 Pages: 341 - 346

    

11. Ravulizumab: First Global Approval

    • Kate McKeage

    AdisInsight Report 14 February 2019 Pages: 347 - 352